Lyell Immunopharma, Inc. (LYEL)
14.3 USD-15.18%close 2026-11-13Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$351.6M52 Week Range: 7.51 – 38.6
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -12.38
The live quote provider is unreachable; the last known close is shown.
Lyell Immunopharma, Inc. (LYEL) is not among the 30 most-held stocks of the tracked superinvestor set. Price 14.30 USD; market cap $351.6M.
Price & valuation
Prev Close16.86
Open—
Day Range—
52 Week Range7.51 – 38.6
Volume—
Avg Volume (3M)—
BetaVolatility vs the market. Above 1: swings harder than the index.1.482 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—
Pro Feature
This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.
Upgrade to ProAbout
SectorHealthcare
Industry—
Employees—
Website—
Frequently Asked Questions
Which superinvestors own LYEL?
Lyell Immunopharma, Inc. (LYEL) is not among the 30 most-held stocks of the tracked superinvestor set.
Is institutional sentiment on LYEL bullish or bearish?
LYEL is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.